189 related articles for article (PubMed ID: 22850945)
1. An evaluation of p16(INK4a) expression in cervical intraepithelial neoplasia specimens, including women with HIV-1.
Nicol AF; Golub JE; e Silva JR; Cunha CB; Amaro-Filho SM; Oliveira NS; Menezes W; Andrade CV; Russomano F; Tristão A; Grinsztejn B; Friedman RK; Oliveira MP; Pires A; Nuovo GJ
Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):571-7. PubMed ID: 22850945
[TBL] [Abstract][Full Text] [Related]
2. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.
Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ
BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065
[TBL] [Abstract][Full Text] [Related]
3. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
Wang R; Li X; Qian M; Niu J; You Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
[TBL] [Abstract][Full Text] [Related]
4. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
Redman R; Rufforny I; Liu C; Wilkinson EJ; Massoll NA
Arch Pathol Lab Med; 2008 May; 132(5):795-9. PubMed ID: 18466028
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
6. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
7. P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies.
Gurrola-Díaz CM; Suárez-Rincón AE; Vázquez-Camacho G; Buonocunto-Vázquez G; Rosales-Quintana S; Wentzensen N; von Knebel Doeberitz M
Gynecol Oncol; 2008 Oct; 111(1):120-4. PubMed ID: 18692882
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results.
Meyer JL; Hanlon DW; Andersen BT; Rasmussen OF; Bisgaard K
Cancer; 2007 Apr; 111(2):83-92. PubMed ID: 17334990
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of p16(INK4a) as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 (CIN 3) treated by cervical conization.
Cardoso FA; Campaner AB; Silva MA
APMIS; 2014 Mar; 122(3):192-9. PubMed ID: 23763281
[TBL] [Abstract][Full Text] [Related]
10. Impact of p16(INK4a) immunohistochemistry staining on interobserver agreement on the diagnosis of cervical intraepithelial neoplasia.
Pacchiarotti A; Galeotti S; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
Am J Clin Pathol; 2014 Mar; 141(3):367-73. PubMed ID: 24515764
[TBL] [Abstract][Full Text] [Related]
11. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
12. P16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions.
Queiroz C; Silva TC; Alves VA; Villa LL; Costa MC; Travassos AG; Filho JB; Studart E; Cheto T; de Freitas LA
Pathol Res Pract; 2006; 202(2):77-83. PubMed ID: 16376485
[TBL] [Abstract][Full Text] [Related]
13. Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias.
Venturoli S; Ambretti S; Mirasoli M; Santini D; Zerbini M; Roda A; Musiani M
Int J Gynecol Pathol; 2008 Oct; 27(4):575-81. PubMed ID: 18753961
[TBL] [Abstract][Full Text] [Related]
14. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
[TBL] [Abstract][Full Text] [Related]
16. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
[TBL] [Abstract][Full Text] [Related]
17. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
[TBL] [Abstract][Full Text] [Related]
18. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
19. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; De Marco L; Giorgi-Rossi P; Pontenani G; Rosso S; Sani C; Sintoni C; Segnan N; Zorzi M; Cuzick J; Rizzolo R; Ronco G;
Lancet Oncol; 2008 Oct; 9(10):937-45. PubMed ID: 18783988
[TBL] [Abstract][Full Text] [Related]
20. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
Dijkstra MG; Heideman DA; de Roy SC; Rozendaal L; Berkhof J; van Krimpen K; van Groningen K; Snijders PJ; Meijer CJ; van Kemenade FJ
J Clin Pathol; 2010 Nov; 63(11):972-7. PubMed ID: 20924035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
